In addition, future studies should be carried out in patients with muscle atrophy to analyze whether there is a correlation between IGF-1, other pro-hypertrophic markers, BDNF levels, an increase in muscle circumference, and an improvement in the subjects’ mood or cognitive processes. The gene discussed is IGF1; the disease is muscle atrophy.